Molina Healthcare Toekomstige groei
Future criteriumcontroles 3/6
Molina Healthcare zal naar verwachting groeien in winst en omzet met respectievelijk 15.4% en 9.4% per jaar. De winst per aandeel zal naar verwachting groeien met 15.5% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 23.1% zijn.
Belangrijke informatie
15.4%
Groei van de winst
15.5%
Groei van de winst per aandeel
| Healthcare winstgroei | 20.8% |
| Inkomstengroei | 9.4% |
| Toekomstig rendement op eigen vermogen | 23.1% |
| Dekking van analisten | Good |
| Laatst bijgewerkt | 08 Nov 2024 |
Recente toekomstige groei-updates
Here's What Analysts Are Forecasting For Molina Healthcare, Inc. (NYSE:MOH) After Its Third-Quarter Results
Oct 27
Revenue Beat: Molina Healthcare, Inc. Beat Analyst Estimates By 5.3%
Apr 26Recent updates
Here's What Analysts Are Forecasting For Molina Healthcare, Inc. (NYSE:MOH) After Its Third-Quarter Results
Oct 27Molina Healthcare Q3 Earnings Preview - Cost Fears Flare Up
Oct 18Returns On Capital Signal Tricky Times Ahead For Molina Healthcare (NYSE:MOH)
Oct 10Are Investors Undervaluing Molina Healthcare, Inc. (NYSE:MOH) By 48%?
Sep 11Does Molina Healthcare (NYSE:MOH) Deserve A Spot On Your Watchlist?
Aug 15Molina Healthcare: Health Insurer Selling For A Discount
Jul 25Molina Healthcare, Inc.'s (NYSE:MOH) Subdued P/E Might Signal An Opportunity
Jul 16Molina Healthcare (NYSE:MOH) Is Reinvesting At Lower Rates Of Return
May 27Molina Healthcare: Stock To Rise As Strategies Drive Strong Future Growth
May 06Revenue Beat: Molina Healthcare, Inc. Beat Analyst Estimates By 5.3%
Apr 26Molina Healthcare (NYSE:MOH) Seems To Use Debt Rather Sparingly
Apr 15Molina Healthcare, Inc.'s (NYSE:MOH) Popularity With Investors Is Clear
Apr 01Should You Be Adding Molina Healthcare (NYSE:MOH) To Your Watchlist Today?
Mar 18An Intrinsic Calculation For Molina Healthcare, Inc. (NYSE:MOH) Suggests It's 35% Undervalued
Mar 04Molina Healthcare: Attractive Risk-Reward Calculus Over All Horizons
Jan 26Molina Healthcare (NYSE:MOH) Will Be Hoping To Turn Its Returns On Capital Around
Jan 16Does Molina Healthcare (NYSE:MOH) Have A Healthy Balance Sheet?
Jan 02Investors Still Waiting For A Pull Back In Molina Healthcare, Inc. (NYSE:MOH)
Dec 20Here's Why We Think Molina Healthcare (NYSE:MOH) Might Deserve Your Attention Today
Dec 06An Intrinsic Calculation For Molina Healthcare, Inc. (NYSE:MOH) Suggests It's 46% Undervalued
Nov 08Molina Healthcare Q3: Robust Growth Potential Yet Underrated Compared To Peers
Oct 30Shareholders Are Optimistic That Molina Healthcare (NYSE:MOH) Will Multiply In Value
Oct 11Molina Healthcare: Stable State Governments Contracts, And Undervalued
Sep 11We Think Molina Healthcare (NYSE:MOH) Can Manage Its Debt With Ease
Sep 08Here's Why Molina Healthcare (NYSE:MOH) Has Caught The Eye Of Investors
Aug 21Molina Healthcare: A Hidden Compounder In Managed Healthcare
Jul 17Investors Shouldn't Overlook Molina Healthcare's (NYSE:MOH) Impressive Returns On Capital
Jul 09Is There An Opportunity With Molina Healthcare, Inc.'s (NYSE:MOH) 43% Undervaluation?
May 29Here's Why We Think Molina Healthcare (NYSE:MOH) Is Well Worth Watching
May 15Molina Healthcare (NYSE:MOH) Has A Rock Solid Balance Sheet
May 01We Think Molina Healthcare (NYSE:MOH) Might Have The DNA Of A Multi-Bagger
Mar 31Molina Healthcare Is Still Appealing In The Face Of Medicaid Redetermination
Feb 21Is Now The Time To Put Molina Healthcare (NYSE:MOH) On Your Watchlist?
Feb 13Molina Healthcare Non-GAAP EPS of $4.10 beats by $0.08, revenue of $8.22B beats by $350M
Feb 08Molina Healthcare (NYSE:MOH) Could Easily Take On More Debt
Jan 29Molina Healthcare takes $200M impairment on its leased space
Dec 29Molina Healthcare (NYSE:MOH) Could Become A Multi-Bagger
Nov 23Molina Healthcare (NYSE:MOH) Has A Rock Solid Balance Sheet
Oct 25Molina Healthcare: Sacrificing Dividend For Growth Can Pay Off
Oct 20Molina initiated at overweight at JP Morgan on recent Medicaid contracts
Oct 04When Should You Buy Molina Healthcare, Inc. (NYSE:MOH)?
Sep 26Molina Healthcare of New Mexico partners with Pyx Health
Sep 13Molina Healthcare reaches 52-week high; up 29% over last year
Aug 26A Look At The Fair Value Of Molina Healthcare, Inc. (NYSE:MOH)
Aug 17Why The 22% Return On Capital At Molina Healthcare (NYSE:MOH) Should Have Your Attention
Aug 04Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 12/31/2026 | 47,162 | 1,651 | 1,614 | 1,992 | 8 |
| 12/31/2025 | 43,467 | 1,411 | 1,778 | 1,787 | 10 |
| 12/31/2024 | 40,368 | 1,258 | 1,021 | 1,373 | 11 |
| 9/30/2024 | 37,544 | 1,144 | 94 | 178 | N/A |
| 6/30/2024 | 36,084 | 1,063 | 179 | 254 | N/A |
| 3/31/2024 | 34,660 | 1,071 | 881 | 960 | N/A |
| 12/31/2023 | 33,003 | 1,091 | 1,578 | 1,662 | N/A |
| 9/30/2023 | 32,503 | 931 | 2,041 | 2,140 | N/A |
| 6/30/2023 | 31,835 | 916 | 1,341 | 1,445 | N/A |
| 3/31/2023 | 31,516 | 855 | 1,226 | 1,326 | N/A |
| 12/31/2022 | 31,101 | 792 | 682 | 773 | N/A |
| 9/30/2022 | 30,303 | 839 | 1,480 | 1,582 | N/A |
| 6/30/2022 | 29,435 | 752 | 1,691 | 1,789 | N/A |
| 3/31/2022 | 28,211 | 689 | 1,830 | 1,914 | N/A |
| 12/31/2021 | 26,984 | 659 | 2,042 | 2,119 | N/A |
| 9/30/2021 | 24,656 | 590 | 2,755 | 2,821 | N/A |
| 6/30/2021 | 22,602 | 632 | 2,144 | 2,202 | N/A |
| 3/31/2021 | 20,377 | 723 | 2,254 | 2,323 | N/A |
| 12/31/2020 | 18,375 | 673 | 1,824 | 1,898 | N/A |
| 9/30/2020 | 17,657 | 807 | 537 | 628 | N/A |
| 6/30/2020 | 16,999 | 797 | 946 | 1,028 | N/A |
| 3/31/2020 | 16,692 | 717 | 249 | 321 | N/A |
| 12/31/2019 | 16,340 | 737 | 377 | 434 | N/A |
| 9/30/2019 | 16,674 | 770 | 239 | 275 | N/A |
| 6/30/2019 | 17,054 | 792 | -508 | -472 | N/A |
| 3/31/2019 | 17,644 | 798 | -491 | -459 | N/A |
| 12/31/2018 | 18,144 | 707 | -344 | -314 | N/A |
| 9/30/2018 | 18,500 | 244 | -369 | -344 | N/A |
| 6/30/2018 | 18,921 | -50 | N/A | 446 | N/A |
| 3/31/2018 | 19,133 | -482 | N/A | 479 | N/A |
| 12/31/2017 | 19,445 | -512 | N/A | 804 | N/A |
| 9/30/2017 | 18,722 | -297 | N/A | 997 | N/A |
| 6/30/2017 | 18,216 | -158 | N/A | 1,067 | N/A |
| 3/31/2017 | 17,581 | 105 | N/A | 1,253 | N/A |
| 12/31/2016 | 17,022 | 52 | N/A | 673 | N/A |
| 9/30/2016 | 16,666 | 129 | N/A | 852 | N/A |
| 6/30/2016 | 15,759 | 133 | N/A | 755 | N/A |
| 3/31/2016 | 14,939 | 139 | N/A | 710 | N/A |
| 12/31/2015 | 13,537 | 143 | N/A | 1,125 | N/A |
| 9/30/2015 | 12,728 | 146 | N/A | 1,125 | N/A |
| 6/30/2015 | 11,620 | 116 | N/A | 1,473 | N/A |
| 3/31/2015 | 10,431 | 85 | N/A | 1,403 | N/A |
| 12/31/2014 | 9,373 | 62 | N/A | 1,060 | N/A |
| 9/30/2014 | 8,324 | 20 | N/A | 920 | N/A |
| 6/30/2014 | 7,564 | 11 | N/A | 537 | N/A |
| 3/31/2014 | 6,881 | 19 | N/A | 381 | N/A |
| 12/31/2013 | 6,417 | 45 | N/A | 190 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De verwachte winstgroei MOH ( 15.4% per jaar) ligt boven de spaarquote ( 2.6% ).
Winst versus markt: De winst van MOH ( 15.4% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 15.6% per jaar).
Hoge groeiwinsten: De winst van MOH zal naar verwachting groeien, maar niet aanzienlijk.
Omzet versus markt: De omzet van MOH ( 9.4% per jaar) zal naar verwachting sneller groeien dan de markt US ( 8.9% per jaar).
Hoge groei-inkomsten: De omzet van MOH ( 9.4% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Het rendement op eigen vermogen MOH zal naar verwachting over 3 jaar hoog zijn ( 23.1 %)